Abstract
The discoveries of the latest ten years have shed new light in understanding the roles of melanocortins and their receptors in brain functions and in the development of different pathologies. Since 1992 when genes encoded melanocortin receptor five subtypes were identified, cloned and characterized, the molecular mechanisms underlying different effects such as skin darkening, behaviour, food intake, anti-inflammatory action, analgesia have been clarified. The contribution of melanocortins and their receptors in the physiological control of organism homeostasis has become as the background for the search of agonists and antagonists of separate receptor subtypes, that can be targeted to the melanocortin receptors and used as therapeutic drugs for the treatment of psychoneuroendocrine and immune system diseases.
Keywords
- Receptor Subtype
- Ventral Tegmental Area
- Melanocortin Receptor
- ACTH Receptor
- Human Dermal Microvascular Endothelial Cell
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Eberle, A.N. (1998) The Melanotropins: Chemistry, Physiology and Mechanisms of Action, Karger, Basel, 556pp.
Nakanish, S.N., Inoue, A., Kita, T., Nakamura, M., Chang, A.C.Y., Cohen, S.N. and Numa, S. (1979) Nucleotide sequence of cloned cDNA for bovine corticotropin-β-lipotropin precursor, Nature 278, 423–427.
Wikberg, J.E.S. (1999) Melanocortin receptors: perspectives for novel drugs,. Eur. J. Pharmacol. 375, 295-310.
Fuchs, R..F. (1912) Die Physiologische Function des Chromatophorsystems als Organ der Physikalishen Warmeregulierung der Poikilotherme, Sitzungsberichte der Physikalisch-Medizinischen Sozietat in Erlangen 44, 134–177.
Lerner, AB.and Lee, T.H. (1995) Isolation of a homogenous melanocyte-stimulating hormone from hog pituitary gland, J. Am. Chem. Soc. 77, 1066–1067.
Xia, Y., Skoog, V., Muceniece, R., Chhajlani, V and Wikberg, J.E.S. (1995) Polyclonal antibodies against human melanocortin MC-1 receptor: preliminary immunohistochemical localisation of melanocortin MC-1 receptor to malignant melanoma cells, Eur. J. Pharmacol. 288, 277–283.
Beyer, C, Kaufmann, K.and Wehner, F. (1990) Importance and function of the melanocyte-stimulating hormone in malignant melanoma. Importance of MSH, Dermatol. Monatsschr. 176, 589–596
Siegrist, W. and Eberle, A.N. (1993) Homologous regulation of the MSH receptor in melanoma cells, J. Recept.Res. 13, 263–81.
De Wied, D. and Jolies, J. (1982) Neuropeptides derived from pro-opiocortin: behavioral, physiological, and neurochemical effects, Physiol.Rev. 62, 976–1059.
Chhajlani, V. and Wikberg, J.E.S. (1992) Molecular cloning and expression of the hyman melanocyte stimulating hormone receptor cDNA, FEBS Lett. 309, 417–420.
Montjoy, K.G., Robbins, L.S., Mortrud, M.T. and Cone, R.D. (1992) The cloning of a family of genes that encode the melanocortin receptors, Science 257, 1248–1251.
Xia, Y., Wikberg, J.E.S. and Chhajlani, V. (1995) Expression of melanocortin 1 receptor in periaqueductal gray matter, Mol. Neurosci. 6, 2193–2196.
Chhajlani, V. (1996) Distribution of cDNA for melanocortin receptor subtypes in human tissues,. Biochem. Biol. Int. 38: 73-80.
Boston, B.A. and Cone, R.D. (1996) Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-LI cell line. Endocrinology 137, 2043–2050.
Luger, T.A., Scholzen, T. and Grabbe, S. (1997) The role of alpha-melanocyte-stimulating hormone in cutaneous biology, J.Invest. Dermatol. Symp. Proc. 2, 87–93.
Star, R.A., Rajora, N., Huang, J., Stock, R.C., Catania, A. and Lipton, J.M. (1995) Evidence of autocrine modulation of macrophage nitric oxide synthase by a-melanocyte-stimulating hormone, Proc. Natl. Acad. Sci.USA 92, 8016–8020.
Hartmeyer, M., Scholzen, T., Becher, E., Bhardwaj, R.S., Schwarz, T. and Luger, T.A (1997) Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce levels of IL-8 upon stimulation with alpha-melanocyte stimulating hormone, J.Immunol. 159, 1930–1937.
Catania, A., Cutuli, M., Garofalo, L., Airaghi, L., Valenza, F., Lipton, J.M. and Gatinoni, L. (2000) Plasma concentrations and anti-L-cytokine effects of a-melanocyte stimulating hormone in septic patients, Cht. Care Med 28, 1403–1407.
Wong, K.Y., Rajora, N., Boccoli, G., Catania, A. and Lipton, J.M. (1997) A. potential mechanism of local anti-inflammatory action of alpha-melanocyte-stimulating hormone within the brain: modulation of tumor necrosis factor-alpha production by human astrocytic cells, Neuroimmunomodulation 4, 37–41.
Xia, Y. and Wikberg, J.E.S. (1996) In situ hybridization biochemical localization of ACTH receptor mRNA in mouse adrenal gland,. Cell Tissue Res. 286: 63-68.
Schioth, H.B., Chhajlani, V., Muceniece, R., Klusa, V. and Wikberg, J.E.S. (1996) Major pharmacological distinction of the ACTH receptor from the other melanocortin receptors, Life Sci. 59, 797–801.
Slominski, A., Ernak, G. and Mihm, M. (1996) ACTH receptor. CYP11 Al, CYP17 and CYP21A2 genes are expressed in skin, J.Clin.Endocrinol. Metab. 81, 2746–2749.
Gantz, I., Konda, Y., Tashiro, T., Shimoto, Y., Miwa, H., Munzert, G., Watson, S.J., DelValle, J and Yamada, T. (1993) Molecular cloning of a novel malanocortin receptor, J.Biol. Chem. 268, 8246–8250.
Lindblom, J., Schioth, HB., Larsson, A, Wikberg, J.E.S. and Bergstrom, L. (1998) Autoradiographic discrimination of melanocortin receptors indicates that the MC3 subtype dominates in the medial brain, Brain Res. 810, 161–171.
Roselli-Rehfuss, L., Mountjoy, K.G., Robbins, L.S., Mortrud, M.T., Low, M.J., Tatro, J.B., Entwistle, M.L., Simerly, R.B. and Cone, R.D. (1993). Identification of receptor for y-melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system,. Proc. Natl. Acad. Sci. USA 90, 8856-8860.
Mountjoy, K.G., Mortrud, M.T., Low, M.J., Simerly, R.B. and Cone, R.D. (1994) Localisation of melanocortin-4 receptor (MC4-R) in endocrine and autonomic control circuits in the brain, Mol. Endocrinol. 8, 1298–1308.
Lindblom, J., Opmane, B., Mutulis, F., Mutule, I., Petrovska, R., Klusa, V., Bergstrom, L. and Wikberg, J.E.S. (2001) The MC4 receptor mediates a-MSH induced release of nucleus accumbens dopamine, Neuroreport 12, 2155–2174.
Takeuchi,S. and Takahashi, S. (1998) Melanocortin receptor genes in the chicken-tissue distributions, Gen. Comp. Endocrinol.112, 220–31.
Schioth, H.B. (2000) The melanocortin receptors: From cloning to treatment of anorexia, Recent Res. Devel.Chemical Engg. 4, 461–485.
Wikberg, J.E.S. (2001) Melanocortin receptors: new opportunities in drug discovery, Exp. Opin. Ther. Patents 11, 61–76.
Prusis, P., Schioth, H.B., Muceniece, R., Herzyk, P., Afshar, M., Hubbard, R.E. and Wikberg, J.E.S. (1997) Modeling of the three-dimensional structure of the human melanocortin-1 receptor using an automated method and docking of a rigid cyclic MSH core peptide,. J. Molecular Graphics Modelling, 15, 307-317.
Schioth, H.B. (2001) The physiological role of melanocortin receptors, Vitamins and Hormones 63, 195–232.
Konda, Y., Gantz, I., DelValle, H.J., Shimoto, Y., Miwa, M. and Yamada, T. (1994) Interaction of dual intra-cellular signalling pathways activated by the melanocortin-3 receptor, J. Biol. Chem. 269, 13162–13166.
Schioth, H.B., Muceniece, R., Wikberg, J.E.S. and Chhajlani, V. (1995) Characterization of melanocortin receptor subtypes by radioligand binding analysis, Eur. J. Pharmacol. 288, 311–317.
Schioth, H.B., Muceniece, R. and Wikberg, J.E.S. (1996) Characterisation of melanocortin 4 receptor by radioligand binding analysis, Pharmacol. Toxicol. 79, 161–165.
Kalden, D.H., Scholzen, T., Brzoska, T. and Luger, R.A. (1999) Mechanisms of the anti-inflammatory effects of alpha-MSH. Role of transcription factor NF-KB and adhesian molecule expression, Ann. NY Acad Sci. 885, 254–261.
Blalock, J.E., Harbour-McMenamin, D.and Smith, E.M. (1985) Peptide hormone shared by the neuroendocrine and immunological systems,. J Immunol. 135 (suppl.), 858-61.
Mandrika, I., Muceniece, R. and Wikberg, J.E.S. (2001) Effects of melanocortin peptides on lipopolisaccharide/interferonγy induced NF-kappaB DNA-binding and nitric oxide production in macrophage-like RAW 264.7 cells: evidence for dual mechanism of action,. Biochem. Pharmacol. 61, 613-621.
Chagnon, V.C., Chen, W.J., Perusse, L., Hagnon, M., Nadeau, A., Wilkinson, W. and Boschard, C. (1997) Linkage and association studies between the melanocortin receptor 4 and 5 genes and obesity-related phenotypes in the Quebec family study,. Mol. Med. 3:663-673.
Wikberg, J.E.S., Muceniece, R., Mandrika, I., Prusis, P., Post, C. and Skottner, A. (2000) New aspects on the melanocortins and their receptors, Pharmacol Res. 42, 393–420.
Poggioli, R., Vergoni, A.V. and Bertolini, A. (1986) ACTH (1-24) and alpha-MSH antagonize feeding behavior stimulated by kappa opiate agonists, Peptides 7, 843–848.
Millenium Pharmaceuticals, US 5932779 (1999).
Lu, D., Willard, D., Patel, J.R., Kadwell, S., Overton, L., Kost, T., Luther, M., Chen, W., Woychik, R.P., Wilkinson, W.O. and Cone, R.D. (1994) Agouti protein is an antagonist of the melanocyte-stimulating hormone receptors, Nature 371, 799–802.
Kask, A., Pahkla, R., Irs, A, Rago, L., Wikberg, J.E.S. and Schioth, H.B. (1999) Long-term administration of MC4 receptor antagonist HS014 causes hyperphagia and obesity in rats, NeuroReport 10, 707–711.
Alvaro, J.D, Tatro, J.B, Quillan, J.M., Fogliano, M., Eisenhard, M., Lerner, M.R., Nestler, E.J. and Duman, R.S. (1996) Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction, Mol. Pharm. 50, 583–591.
Adán, R.A.H. and Gispen, W.H. (1997) Brain melanocortin receptors: from cloning to function, Peptides 18, 1279–1287.
Lankhorst, A.J., Duis, S.E., ter Laak, M.P., Joosten, E.A., Hamers, F.P. and Gispen, W.H. (1996) Functional recovery after central infusion of alpha-melanocyte-stimulating hormone in rats with spinal cord contusion injury, J Neurotrauma 16, 323–31.
Spanagel, R.and Zieglgansberger, W. (1997) Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes, TIPS 18, 54–59.
Klusa, V., Svirskis, S., Opmane, B., Muceniece, R.E. and Wikberg, J.E.S. (1999) Behavioural responses of γ-MSH peptides administered into the rat ventral tegmental area, Acta Physiol.Scand. 67, 99–104.
Opmane, B., Klusa, V., Svirskis, S., Bergstrom, L. and Wikberg, J. (2001) The influence of α-, γl-and γ2-MSH on the rat mesolimbic dopaminergic system, in M.Pilmane (ed.),. Faculty of Medicine Scientific Papers, IV (I), University of Latvia, Riga, pp. 75-85.
Wikberg, J.E.S., Germane, S., Svirskis, S., Opmane, B., Muceniece, R., Skujins, A., Post, C. and Klusa V. (1999) Comparison of behavioural pharmacology of α-, γl-and γ2-MSH,. Abtracts Soc.Neurosci, 25, 67.
Klusa, V., Germane, S., Svirskis, S., Opmane, B. and Wikberg, J.E.S. (2001) The y2-MSH peptide mediates a central analgesic effect via a GABA-ergic mechanism that is independent from activation of melanocortin receptors, Neuropeptides 35, 50–57.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media Dordrecht
About this paper
Cite this paper
Klusa, V., Jansone, B., Svirskis, S., Rumaks, J., Muceniece, R. (2003). The Fundamental Role of Melanocortins in Brain Processes. In: Schneider, M.P. (eds) Chemical Probes in Biology. NATO Science Series, vol 129. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0958-4_21
Download citation
DOI: https://doi.org/10.1007/978-94-007-0958-4_21
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-1770-4
Online ISBN: 978-94-007-0958-4
eBook Packages: Springer Book Archive